Aclaris Therapeutics Inc. (ACRS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aclaris Therapeutics Inc.

    NASDAQ: ACRS · Real-Time Price · USD
    1.86
    0.02 (1.09%)
    At close: Oct 03, 2025, 3:59 PM
    1.84
    -1.08%
    After-hours: Oct 03, 2025, 06:20 PM EDT

    Aclaris Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -132.06M -88.48M -86.91M -90.86M
    Depreciation & Amortization
    		 807K 863K 797K 923K
    Stock-Based Compensation
    		 10.86M 20.54M 15.04M 14.06M
    Other Working Capital
    		 15.13M 10.68M -1.7M -5.15M
    Other Non-Cash Items
    		 89.41M -20.27M 4.7M 24.34M
    Deferred Income Tax
    		 n/a -367K n/a 752K
    Change in Working Capital
    		 10.92M 9.39M -1.2M -1.34M
    Operating Cash Flow
    		 -20.07M -78.33M -67.57M -52.13M
    Capital Expenditures
    		 -121K -1.31M -605K -308K
    Cash Acquisitions
    		 n/a n/a -13.23M 167.32M
    Purchase of Investments
    		 -119.98M -135.68M -164.75M -235.15M
    Sales Maturities Of Investments
    		 86.14M 183.2M 177.99M 67.83M
    Other Investing Acitivies
    		 -35.81M n/a 13.23M -167.32M
    Investing Cash Flow
    		 -69.77M 46.22M 12.63M -167.63M
    Debt Repayment
    		 n/a n/a n/a -11.48M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -377K -8K 123K -1.67M
    Financial Cash Flow
    		 74.54M 26.71M 72.87M 225.05M
    Net Cash Flow
    		 -15.31M -5.4M 17.93M 5.29M
    Free Cash Flow
    		 -20.2M -79.63M -68.17M -52.44M

    Add to Watchlist